Cargando…

Effects of trimetazidine on ventricular remodeling in coronary artery disease patients with left ventricular hypertrophy: the rationale and design of a randomized controlled trial

BACKGROUND: Trimetazidine is a metabolic anti-ischemic agent, which increases the tolerance of cardiomyocytes to ischemia. However, few studies have explored the effect of trimetazidine on ventricular remodeling in coronary artery disease (CAD) patients undergoing percutaneous coronary intervention...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Lili, Luan, Yi, Li, Ya, Wang, Min, He, Jialin, Jin, Chongying, Zhang, Wenbin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7275498/ https://www.ncbi.nlm.nih.gov/pubmed/32503494 http://dx.doi.org/10.1186/s12872-020-01557-3

Ejemplares similares

Correlation of Coronary Artery Disease and Left Ventricular Hypertrophy
por: Khalid, Khizer, et al.
Publicado: (2021)

Effects of Trimetazidine on Right Ventricular Function and Ventricular Remodeling in Patients with Pulmonary Artery Hypertension: A Randomised Controlled Trial
por: Verdejo, Hugo E., et al.
Publicado: (2023)

Trimetazidine Protects against Smoking-Induced Left Ventricular Remodeling via Attenuating Oxidative Stress, Apoptosis, and Inflammation
por: Zhou, Xiang, et al.
Publicado: (2012)

Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study
por: Patel, Sheila K., et al.
Publicado: (2017)

IMPACT OF BLOOD PRESSURE COMPONENTS ON LEFT VENTRICULAR HYPERTROPHY REMODELING
por: Kunišek, Juraj, et al.
Publicado: (2018)

Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double-blind placebo-controlled study
por: Rosano, Giuseppe MC, et al.
Publicado: (2003)

Rationale and Design of the Efficacy and Safety of Esaxerenone in Hypertensive Patients With Left Ventricular Hypertrophy (ESES-LVH) Study　― Protocol for a Multicenter, Open-Label, Exploratory Interventional Study ―
por: Sueta, Daisuke, et al.
Publicado: (2022)

Association of Arterial Stiffness and Electrocardiography-Determined Left Ventricular Hypertrophy with Left Ventricular Diastolic Dysfunction
por: Hsu, Po-Chao, et al.
Publicado: (2012)

The remodelling index risk stratifies patients with hypertensive left ventricular hypertrophy
por: Le, Thu-Thao, et al.
Publicado: (2020)

Effect of Exercise Training on Left Ventricular Remodeling in Diabetic Patients with Diastolic Dysfunction: Rationale and Design
por: Asrar ul Haq, Muhammad, et al.
Publicado: (2014)

Moexipril and left ventricular hypertrophy
por: Chrysant, George S, et al.
Publicado: (2007)

Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013)

Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers
por: Bacharova, Ljuba, et al.
Publicado: (2023)

Left Ventricular Diastolic Function: Comparison of Slow Coronary Flow Phenomenon and Left Ventricular Hypertrophy in the Absence of Obstructive Coronary Disease
por: Semerdzhieva, Niya E, et al.
Publicado: (2022)

A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
por: Mohan, Mohapradeep, et al.
Publicado: (2019)

Nocturnal Blood Pressure Pattern Affects Left Ventricular Remodeling and Late Gadolinium Enhancement in Patients with Hypertension and Left Ventricular Hypertrophy
por: Yokota, Hajime, et al.
Publicado: (2013)

Myocardial Energetics in Left Ventricular Hypertrophy
por: Jameel, Mohammad N, et al.
Publicado: (2009)

Study on the correlation between Left Ventricular Hypertrophy and Coronary Artery disease in the very elderly patients with hypertension
por: Sun, Jian-hua, et al.
Publicado: (2021)

Accuracy of advanced versus strictly conventional 12-lead ECG for detection and screening of coronary artery disease, left ventricular hypertrophy and left ventricular systolic dysfunction
por: Schlegel, Todd T, et al.
Publicado: (2010)

Effect of left ventricular hypertrophy on long-term survival of patients with coronary artery disease following percutaneous coronary intervention
por: Brown, David L.
Publicado: (2009)

The Effect of Prophylactic Intravenous Amiodarone Administration on Reperfusion Ventricular Fibrillation in Patients With Left Ventricular Hypertrophy Undergoing Cardiopulmonary Bypass Surgery: Protocol for a Randomized Double-Blind Clinical Trial
por: Zhou, Xiaokai, et al.
Publicado: (2023)

Effect of trimetazidine treatment on the transient outward potassium current of the left ventricular myocytes of rats with streptozotocin-induced type 1 diabetes mellitus
por: Xiang, Yu-luan, et al.
Publicado: (2012)

Surgical Ventricular Restoration to Reverse Left Ventricular Remodeling
por: Castelvecchio, Serenella, et al.
Publicado: (2010)

Electrocardiographic Criteria for Left Ventricular Hypertrophy in Children
por: Rijnbeek, Peter R., et al.
Publicado: (2008)

The Role of ECG in the Diagnosis of Left Ventricular Hypertrophy
por: Bacharova, Ljuba, et al.
Publicado: (2014)

Left ventricular hypertrophy, inflammation, and insulin resistance
por: Öncel, Can Ramazan
Publicado: (2016)

Crim1 suppresses left ventricular hypertrophy
por: Yang, Long, et al.
Publicado: (2019)

Left ventricular apical hypertrophy (Yamaguchi disease)
por: Al Lawati, Hatim, et al.
Publicado: (2021)

Left ventricular remodeling and hypertrophy in patients with aortic stenosis: insights from cardiovascular magnetic resonance
por: Dweck, Marc R, et al.
Publicado: (2012)

Phenotyping patterns of left ventricular remodeling and hypertrophy in systemic hypertension by cardiac magnetic resonance (CMR)
por: Rodrigues, Jonathan C, et al.
Publicado: (2015)

Utility of Three Adiposity Indices for Identifying Left Ventricular Hypertrophy and Geometric Remodeling in Chinese Children
por: Wang, Huan, et al.
Publicado: (2021)

Influence of elderly patients' coronary artery lesion severity on cardiac remodeling and left ventricular function
por: Wang, Chao, et al.
Publicado: (2018)

Cardiac remodelling in association with left ventricular dyssynchrony and systolic dysfunction in patients with coronary artery disease
por: Hämäläinen, Hanna, et al.
Publicado: (2022)

Left ventricular shape remodelling predicts major arrhythmic events in stable coronary artery disease
por: Zaidi, H, et al.
Publicado: (2023)

The effects of nocturnal hemodialysis compared to conventional hemodialysis on change in left ventricular mass: Rationale and study design of a randomized controlled pilot study
por: Walsh, Michael, et al.
Publicado: (2006)

Rationale and design of a multi-centre randomised controlled trial of individualised cooled dialysate to prevent left ventricular systolic dysfunction in haemodialysis patients
por: Odudu, Aghogho, et al.
Publicado: (2012)

Rationale and methods of a randomized trial evaluating the effect of neprilysin inhibition on left ventricular remodelling
por: Docherty, Kieran F., et al.
Publicado: (2020)

The Relationship between Adiponectin and Left Ventricular Mass Index Varies with the Risk of Left Ventricular Hypertrophy
por: Lee, Yonggu, et al.
Publicado: (2013)

Echocardiographic assessment of inappropriate left ventricular mass and left ventricular hypertrophy in patients with diastolic dysfunction
por: Shemirani, Hasan, et al.
Publicado: (2012)

Association of obesity phenotypes with left ventricular mass index and left ventricular hypertrophy in children and adolescents
por: Genovesi, Simonetta, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6pbdo4mko9vvpuk4h32abibert